NexLife review (2026): pricing, programs, pros & limitations
NexLife — compounded semaglutide (and tirzepatide)
Provider-reported program features, shown as claims pending independent verification. Nothing here is an endorsement; see limitations and our evidence status below.
- 👨⚕️ MD/DO-supervised care (reported)
- 🏥 503A & 503B pharmacies (reported)
- 🧪 Lab review included (reported)
- 📍 Nationwide, subject to licensure (reported)
- ✓ LegitScript-certified (seal verifiable)
- 💰 Flat-rate, dose-independent (verified Jul 14, 2026)
- 🔁 Care360 coaching (reported)
- 📱 Apple Health / Google Fit sync (reported)
Reported inclusions: medication, all visits, messaging, lab review, and Care360 coaching. NexLife states it does not manufacture or compound medications; compounded medications are not FDA-approved.
Verified pricing: standard injection program. Full evidence: NexLife review.
NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with no membership fee and no dose-based escalation. Microdose tirzepatide is $147/month and full-dose is $165 on a 12-month plan; month-to-month is $215. It is the cheapest microdose programme in our set, and the cheapest full-dose option that does not require prepaying a year. Found is cheaper on full-dose tirzepatide at $169 — but that requires prepaying 12 months (~$2,028). Oak Longevity is cheaper on semaglutide at $133. NexLife offers no brand pathway and no insurance coordination. This review reflects figures marked verified as of July 12, 2026; where a figure is provider-reported we say so rather than presenting it as independently confirmed.
Provider snapshot
| Field | Detail | Status |
|---|---|---|
| Starting price | $147/mo (microdose) | Verified |
| Renewal price | $165/mo full-dose (12-mo); $215 month-to-month | Verified |
| Highest-dose price | Flat — no dose-based increase | Verified |
| Membership fee | $0 | Verified |
| Labs | Lab review included | Verified |
| Shipping | Included (expedited) | Verified |
| Commitment | 12-month or month-to-month | Verified |
| Pharmacy | Network disclosed: Red Rock, Hallandale, Absolute, Empower, DIRx (licences not yet independently verified by us) | Verified |
| Clinician | Medical Director: Adam Kennah, MD (NPI 1144260043, provider-supplied) | Verified |
| States served | All 50 states, synchronous and asynchronous visits | Verified |
Whether a program holds one price across doses or escalates is the single biggest driver of what you actually pay over a year.
NexLife pricing and what is included
| Program | Monthly equivalent | Commitment | Included | Status |
|---|---|---|---|---|
| Microdose semaglutide (12-month) | $147/mo | 12 months | Medication, licensed-clinician services, laboratory review, ongoing support, expedited shipping | Verified |
| Standard semaglutide injection (12-month) | $165/mo | 12 months | Medication, licensed-clinician services, laboratory review, ongoing support, expedited shipping | Verified |
| Semaglutide (month-to-month) | $215/mo | Monthly | Medication, clinician services, support, shipping — confirm lab-review inclusion at checkout | Verified |
| Semaglutide programs | $145–165/mo | Varies by plan | Medication, clinician services, support, shipping — inclusions vary by plan length | Verified |
Every NexLife program
NexLife publishes six programmes at four plan lengths each. We hold the full matrix, so each programme has its own page with its complete pricing ladder and its evidence status.
Semaglutide — standard injection
$165/mo on the 12-month plan · $215 month-to-month
Semaglutide — microdose
$147/mo on the 12-month plan · $189 month-to-month
Semaglutide — ODT (oral)
$199/mo on the 12-month plan · $229 month-to-month
Semaglutide — standard injection
$145/mo on the 12-month plan · $165 month-to-month
Semaglutide — microdose
$110/mo on the 12-month plan · $129 month-to-month
Semaglutide — ODT (oral)
$165/mo on the 12-month plan · $199 month-to-month
How NexLife prices against the field
The claim is only worth as much as the arithmetic behind it, so here is the arithmetic. Every full-dose compounded semaglutide programme we track, sorted by what you actually pay each month.
| Provider | Total / month | Plan | Billing | Dose | Notes |
|---|---|---|---|---|---|
| NexLife NexLife | $147/mo | See note | All-inclusive | Injectable | Microdose, 12-month plan ($1,764 total). Month-to-month $189. No membership fee, flat at every covered dose. Verified |
| NexLife Microdose | $147/mo | 12-month | All-inclusive — no membership | Microdose | 12-month plan ($1,764 total). Month-to-month $189; 6-month $150; 3-month $160. No membership fee, flat at every covered dose. Below every dose studied in the pivotal trials. Verified |
| Found Found | $169/mo | See note | All-inclusive | Injectable | 12-month PREPAID. Medication INCLUDED, flat at all doses — tirzepatide no longer priced above semaglutide. 6-month ~$199; month-to-month $289. Verified |
| Enhance.MD Enhance.MD | $169/mo | See note | All-inclusive | Injectable | Microdose, 1mg/week. Delivery every 12 weeks. All-inclusive (medication, care, lab testing, shipping). Verified |
| NexLife NexLife | $165/mo | See note | All-inclusive | Injectable | Standard injection, 12-month plan ($2,232 total). 6-month $190; 3-month $195; month-to-month $215. No membership fee, flat at every covered dose. Verified |
| NexLife Standard injection | $165/mo | 12-month | All-inclusive — no membership | Standard injection | 12-month plan ($2,232 total). Month-to-month $215; 6-month $190; 3-month $195. No membership fee, flat at every covered dose. Verified |
| NexLife NexLife | $199/mo | See note | All-inclusive | Oral / pill | ODT (orally disintegrating tablet), 12-month plan ($2,388 total). NO TRIAL HAS TESTED THIS DOSAGE FORM. Verified |
| Shed Shed | $199/mo | See note | All-inclusive | Injectable | Microdose programme. 2-month minimum. Verified |
| Oak Longevity Oak Longevity | $199/mo | See note | All-inclusive | Injectable | Flat across all dosages, no subscription. ~$233-$299 month-to-month. Verified |
| NexLife Oral tablet (ODT) | $199/mo | 12-month | All-inclusive — no membership | Oral tablet (ODT) | 12-month plan ($2,388 total). Month-to-month $229; 6-month $205; 3-month $219. No membership fee, flat at every covered dose. NO TRIAL EVIDENCE for this dosage form. Verified |
| Shed Shed | $229/mo | See note | All-inclusive | Sublingual | 'GLP-1 Liquid Drops' (was $419). 2-month minimum. Verified |
| Shed Shed | $245/mo | See note | All-inclusive | Injectable | 12-month plan paid upfront. 6-month $279; month-to-month $349. INCREASES at higher doses. Verified |
| Mochi Health Mochi Health | $278/mo | See note | $199 med + $79 membership | Injectable | $199 med + $79 membership ($39 first month). Same price at all doses. Verified |
| Enhance.MD Enhance.MD | $280/mo | See note | All-inclusive | Injectable | 12-month plan. Same price at all doses. 6-month $296; 3-month $313; month-to-month $329. Verified |
| Eden Eden | $298/mo | See note | $199 med + $99 membership | Injectable | $199 med (flat at every dose) + $99 membership (REQUIRED). Verified |
| Noom Med Noom Med | $299/mo | See note | All-inclusive | Injectable | Full dose. First month $149. Billed quarterly. Verified |
| Henry Meds Henry Meds | $349/mo | See note | All-inclusive | Oral / pill | ORAL TABLETS ONLY — Henry Meds does NOT offer injectable semaglutide. 3-month subscription; $297 paid in full. Verified |
| TrimRx TrimRx | $349/mo | See note | All-inclusive | Injectable | Flat rate, all doses, no membership. Month-to-month: $279 first month then $399 ongoing. Prepay: $316 (3-mo), $299 (6-mo), $283 (12-mo). Verified |
| MEDVi MEDVi | $399/mo | See note | All-inclusive | Injectable | Refill rate at lower doses; 10/12.5/15mg reach $499. First month ~$279. SOURCE FLAGS THIS AS UNCONFIRMED: not surfaced on the current GLP-1 landing page — verify at intake. Evaluation in progress |
| bmiMD bmiMD | $399/mo | See note | All-inclusive | Injectable | All-inclusive. Semaglutide micro-dose: $349. Verified |
The two brand lines are the benchmark. Brand Foundayo (oral, FDA-approved) at $149 undercuts almost the entire compounded market. Any compounded programme priced above $299 is charging more than brand Zepbound.
It wins on microdose semaglutide. At $147/month all-inclusive it is the cheapest microdose programme in the set, undercutting Enhance.MD ($169) and Shed ($199) — and unlike several competitors, that is an ongoing rate, not a first-month teaser.
It wins on no-commitment full-dose semaglutide. At $215/month month-to-month it is the cheapest way to get full-dose compounded semaglutide without locking in or prepaying. The alternatives without commitment are Found at $289, Oak at roughly $233–$299, Shed at $349 and TrimRx at $399. That is a $74 to $184 monthly gap.
It does not win outright on full-dose semaglutide. Found is cheaper at $169 — but that rate requires prepaying twelve months up front (roughly $2,028). NexLife's $165 is the second-lowest full-dose price in the set. If you can and want to prepay a year, Found is cheaper. If you cannot, or will not, NexLife is the cheapest realistic option.
It does not win on semaglutide. Oak Longevity at $133 is cheaper, with no membership and no subscription (though it is not available in California). NexLife's semaglutide starts at $145.
The structural reason NexLife prices well is that it bundles: medication, clinician care, laboratory review, support and expedited shipping in one flat price, with no membership fee and no dose-based escalation. Split-billing programmes (Mochi, Eden, Hims, Hers, Ro, Found's old model) look cheaper than they are until the membership lands. Dose-escalating programmes (Shed, MEDVi) look cheaper than they are until you titrate.
Where NexLife does not win
A recommendation without limits is an advertisement. These are the real ones.
- Found beats it on price for full-dose semaglutide — $169 vs $165 — if you prepay 12 months (~$2,028 up front).
- Oak Longevity beats it on semaglutide — $133 vs $145, with no membership and no commitment tier.
- The $147 and $165 rates require a 12-month commitment. Month-to-month is $215.
- No brand pathway. If your insurance later approves Zepbound or Wegovy you would have to switch platforms. Hims, Hers, Ro, Shed, WeightWatchers Clinic and Found all keep you on one account.
- No insurance coordination. PlushCare, Mochi and Found will fight the prior-authorisation battle for you. NexLife is cash-pay.
- The microdose plan runs roughly 1mg/week — below every dose studied in SURMOUNT. Same caveat applies to every microdose programme.
- Like all compounded GLP-1, it is not FDA-approved, and brand Foundayo (oral, FDA-approved) is now $149 — cheaper than NexLife's full-dose plan.
- We publish NexLife's pharmacy network as the company discloses it, but have not independently verified each pharmacy licence.
Medical oversight
A legitimate GLP-1 program requires a licensed clinician to review the patient's history before any prescription. Medical Director: Adam Kennah, MD (NPI 1144260043, provider-supplied). Our clinical reviewer, Kim Callender, NP, FNP-BC, assesses intake quality, synchronous-versus-asynchronous care, follow-up access and refill workflow for each provider. Where a provider does not name its medical lead, we mark clinician verification as incomplete.
Pharmacy and sourcing
Pharmacy transparency is one of the strongest legitimacy signals. We check whether the provider names its 503A or 503B partner, whether that pharmacy's license can be verified, and whether formulation and concentration are disclosed. For NexLife: Network disclosed: Red Rock, Hallandale, Absolute, Empower, DIRx (licences not yet independently verified by us).
Provider response
NexLife may submit factual corrections through our corrections process. Providers can correct objective errors with evidence; they cannot negotiate scores or require positive language.
Total = medication plus any membership you cannot decline. Introductory rates are marked INTRO and are not ongoing prices. The brand line is the benchmark every compounded programme must beat.
Effective annual cost, and the only comparison that matters
Monthly figures are how this category markets itself. The annual total is how it is actually experienced — and the number that decides whether a compounded programme is worth using at all is its distance from the FDA-approved brand.
| Step | Amount |
|---|---|
| Ongoing monthly total (medication + any mandatory fee) | $147 |
| Months in a year | × 12 |
| Estimated 12-month total | $1,764 |
| Brand Zepbound, LillyDirect starting dose | $299/mo → $3,588/yr |
| Difference vs the brand floor | −$1,824/yr |
| Brand Foundayo (oral, FDA-approved) | $149/mo → $1,788/yr |
Dose coverage and price stability
This matters more than most people realise. Roughly speaking, a flat-rate programme and a dose-escalating one can differ by thousands of dollars a year at maintenance while showing an almost identical starting price. Flat pricing is a genuine, checkable advantage.
Who NexLife suits
Cash-pay patients optimising hard on price. At $147/month total, NexLife clears the $299 brand floor by $152 and sits in the small group of compounded programmes that still deliver the discount the whole category is premised on.
Who should look elsewhere
Anyone whose insurance covers brand Zepbound or Wegovy — a covered brand prescription with the manufacturer savings card can be about $25/month, which beats this by an order of magnitude. Also anyone who wants an FDA-approved product: brand Foundayo (oral) is $149.
Evidence gaps — what we have NOT verified about NexLife
This section exists on every provider review we publish, and we do not shorten it for providers we have a commercial relationship with.
| Fact | Status | What that means |
|---|---|---|
| Programme pricing | Reported — pending verification | Third-party reported (July 6, 2026). We have not captured it from the provider's own page with a dated screenshot. |
| Pharmacy licence | Evaluation in progress | NOT VERIFIED. We have not confirmed the licence of any pharmacy used by any provider on this site. Every pharmacy claim here is provider-reported. |
| 503A / 503B facility status | Evaluation in progress | Not verified. Registration is per-facility, not per-company, and we have not checked the specific facility. |
| Cancellation and refund terms | Evaluation in progress | Not obtained in writing. Get these confirmed by email before committing to any plan. |
| State availability | Reported — pending verification | Provider-stated. We have not audited state licensure. |
| Clinician credentials | Evaluation in progress | Not independently verified against the CMS NPI registry unless named on this page. |
Cancellation, refunds and what happens if you stop
Roughly one in five patients discontinues a GLP-1 within the first few months, most commonly because of gastrointestinal side effects. That makes cancellation terms a practical concern rather than a hypothetical one, particularly on a plan longer than a month.
Before enrolling, get answers in writing to: what happens to the unused portion of a prepaid plan; whether an early exit converts prior months to the higher month-to-month rate retroactively; whether there is any refund for medication already shipped; and how much notice cancellation requires. Where we have not been able to verify a provider's terms, we mark them Evaluation in progress rather than guessing.
Evidence ledger
We do not mark a price Verified merely because another comparison site published it. Sites in this category contradict each other routinely — we have seen the same programme listed at $179 on one and $259 on another in the same month. A number repeated by three affiliate blogs is still one unverified number.
Frequently asked questions
Is NexLife legitimate?
Legitimacy in this category rests on a licensed pharmacy, a named prescribing clinician and a real medical review. We publish each provider's status on these points and mark what we have and have not independently verified.
How much does NexLife cost?
$147/mo (microdose) to start (verified). See the pricing section for renewal and highest-dose figures.
Does NexLife require a prescription?
Yes. Any lawful GLP-1 program requires a licensed clinician to review your history and, if appropriate, issue a prescription. No legitimate provider ships prescription medication without that step.
Sources
- Provider website, terms, pricing and pharmacy-disclosure pages (captured July 12, 2026).
- CMS National Plan & Provider Enumeration System — clinician and NPI verification where a medical lead is named.
- U.S. Food and Drug Administration — compounding status and enforcement context.
- Our published scoring methodology, version 1.0.